UCM uscom limited

0.00%

1.9¢

Agree. The H1 report is gonna be bad - we know that for sure....

First 26 Last

Share
Profile

Follow
Charterrierist

6,029 Posts.

688

28/02/20

22:52

Post #: 43227907
Share

Originally posted by Wise_One ↑

What a fantastic presentation and a clear & concise way to portray the insane demand tailwinds behind this company.

From a cash perspective, its worth noting that they projected to be Cash Flow Positive this Qtr (from last 4C) so there is no CR on its way... All the demand / sales from China is based on a cash-upfront basis. So they physically get the cash from their customer before packing/shipping the goods.

UCM has been under the radar of the investment community for some time as it's required a lot of 'joining the dots' for new investors & lets face it, many of us are lazy.

I outlined in a previous post why I thought it was a slam-dunk (here - https://hotcopper.com.au/threads/cl....5246113/page-2?post_id=43134880#.Xlg5E2cViJA) after Rob did a media interview.

The below slide (Slide 13) also outlines what Rob was explaining in the interview:

View attachment 2019910

From the presentation today, the following chestnuts stand out as very bullish indicators for the company. (Slide 10 extract below)

View attachment 2019901

So USCOM Technology has been specifically recommended by the Chinese Government Coronavirus Guidelines

Slide 11 & 12 extracts (below) outlines how their technology supports Cardiovascular systems and their non-invasive, dopplar nature mean that it's world class, patent protected, FDA / NMPA approved & without competition

View attachment 2019907

Finally - We are all eagerly awaiting a further update on their sales / orders which have been significantly boosted from this outbreak. The last outbreak we received was on 10-Feb for the first 5 weeks of the calendar year which showed a 121% increase in sales over the PcP.

Furthermore, in that release, they note that the first device specifically commissioned on 23rd Jan 2020

Given the deadline for the half-yearly reports is prior to the commencement of trade Monday morning, I am betting that we get a sales further sales update with those accounts.

So that could land anytime today, but before trading commences Monday

I'm a happy little holder of this gem!

Expand

Agree. The H1 report is gonna be bad - we know that for sure. But we also know things are rapidly changing for the better. Hopefully some kind of sales update on Monday either with the report or separately.

UCM Price at posting: 31.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 26 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.9¢		Change 0.000(0.00%)		Mkt cap ! $4.759M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	500000	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	46000	1

View Market Depth

No.	Vol.	Price($)
1	500000	0.014
1	132270	0.012
1	100000	0.010
1	150000	0.008
2	2000000	0.001

Price($)	Vol.	No.
0.019	46000	1
0.020	63256	1
0.021	24866	1
0.022	6549	1
0.055	95083	2

Last trade - 16.21pm 27/06/2025 (20 minute delay)

UCM (ASX) Chart

Day chart unavailable

Agree. The H1 report is gonna be bad - we know that for sure....

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Agree. The H1 report is gonna be bad - we know that for sure....

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News